↓ Skip to main content

Dove Medical Press

The Emerging Role of Dual GLP-1 and GIP Receptor Agonists in Glycemic Management and Cardiovascular Risk Reduction

Overview of attention for article published in Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, April 2022
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#21 of 1,197)
  • High Attention Score compared to outputs of the same age (97th percentile)
  • High Attention Score compared to outputs of the same age and source (97th percentile)

Mentioned by

news
15 news outlets
reddit
1 Redditor
video
1 YouTube creator

Citations

dimensions_citation
24 Dimensions

Readers on

mendeley
54 Mendeley
Title
The Emerging Role of Dual GLP-1 and GIP Receptor Agonists in Glycemic Management and Cardiovascular Risk Reduction
Published in
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, April 2022
DOI 10.2147/dmso.s351982
Pubmed ID
Authors

Ali A Rizvi, Manfredi Rizzo

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 54 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 54 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 6 11%
Student > Bachelor 6 11%
Other 4 7%
Student > Postgraduate 4 7%
Researcher 2 4%
Other 6 11%
Unknown 26 48%
Readers by discipline Count As %
Medicine and Dentistry 9 17%
Biochemistry, Genetics and Molecular Biology 6 11%
Pharmacology, Toxicology and Pharmaceutical Science 5 9%
Chemistry 3 6%
Psychology 1 2%
Other 2 4%
Unknown 28 52%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 115. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 03 May 2024.
All research outputs
#373,446
of 25,839,971 outputs
Outputs from Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
#21
of 1,197 outputs
Outputs of similar age
#10,236
of 450,993 outputs
Outputs of similar age from Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
#1
of 48 outputs
Altmetric has tracked 25,839,971 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,197 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.0. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 450,993 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 97% of its contemporaries.
We're also able to compare this research output to 48 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 97% of its contemporaries.